STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Balyasny Asset Management Discloses 5.78M Shares (9.99%) in Verastem

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Verastem Inc. is reported to have a substantial passive investor position held by Balyasny-related entities and Dmitry Balyasny totaling 5,777,396 shares, equal to 9.99% of the company's 54,949,170 outstanding shares (basis: the issuer's outstanding share count as of May 12, 2025). The reported position includes 1,571,428 shares issuable upon exercise of warrants, but those warrants cannot be exercised to the extent doing so would cause beneficial ownership to exceed the 9.99% blocker. The shares are held through Atlas Diversified Master Fund, Ltd. as the direct holder while Balyasny entities serve as manager/owners of the reporting group. The filing certifies the holdings are held in the ordinary course of business and not for the purpose of changing or influencing control.

Positive

  • Material passive stake: Reporting Persons beneficially own 5,777,396 shares, representing a material 9.99% ownership of Verastem common stock.
  • Passive filing and certification: The statement on Schedule 13G includes a certification that the securities are held in the ordinary course and not to influence control, indicating a non-activist posture.

Negative

  • Warrant exercise limited: The position includes 1,571,428 shares issuable upon exercise of warrants but the warrants cannot be exercised to the extent beneficial ownership would exceed the 9.99% blocker, capping immediate upside from warrant conversion.

Insights

TL;DR: A near-10% passive stake signals significant investor interest but the 9.99% blocker limits additional immediate upside from warrant exercise.

The Reporting Persons disclose beneficial ownership of 5,777,396 shares representing 9.99% of Verastem's common stock on the stated outstanding-share basis. The position explicitly includes 1,571,428 shares issuable upon exercise of warrants, but the warrants contain a contractual 9.99% exercise cap that prevents automatic dilution above that threshold. The filing is on Schedule 13G and includes a certification the position is held in the ordinary course and not to influence control, which suggests a passive investment posture rather than an activist or control-seeking stance.

TL;DR: Ownership is material (>5%) but presented as passive; governance impact is limited today because the filer disclaims intent to influence control and warrants are blocked above 9.99%.

The group structure shows ownership held through an investment fund (Atlas Diversified Master Fund, Ltd.) with Balyasny entities exercising managerial voting/investment authority. While a near-10% stake can be significant for voting power, the filing's Schedule 13G posture and the explicit certification indicate no present intent to change or influence control. The 9.99% blocker on warrant exercise is a key contractual limitation affecting potential future increases in voting or economic exposure.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Balyasny Asset Management L.P.
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:08/10/2025
BAM GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:08/10/2025
Balyasny Asset Management Holdings LP
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:08/10/2025
Dames GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:08/10/2025
Dmitry Balyasny
Signature:/s/ Dmitry Balyasny
Name/Title:Dmitry Balyasny / Self
Date:08/10/2025

FAQ

How many Verastem (VSTM) shares do Balyasny-related reporting persons beneficially own?

The Reporting Persons beneficially own 5,777,396 shares of Verastem common stock, representing 9.99% of the outstanding shares on the stated basis.

Does the reported stake include warrants or other convertible instruments?

Yes. The total includes 1,571,428 shares issuable upon exercise of warrants, but those warrants are subject to a 9.99% exercise blocker.

Who are the Reporting Persons filing this Schedule 13G for VSTM?

The filing is by Balyasny Asset Management L.P., BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC, and Dmitry Balyasny.

Is the filing an indication of an attempt to influence Verastem's control or management?

No. The Schedule 13G certification states the securities are held in the ordinary course of business and were not acquired to change or influence control.

Through which vehicle are the shares held?

The direct holder of the reported shares is Atlas Diversified Master Fund, Ltd., an investment management client of Balyasny Asset Management.
Verastem

NASDAQ:VSTM

VSTM Rankings

VSTM Latest News

VSTM Latest SEC Filings

VSTM Stock Data

801.40M
70.82M
0.82%
89.08%
25.94%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEEDHAM